CompletedNot Applicable

Retrospective Multicentre Study on the Impact of Neonatal Screening for Congenital Adrenal Hyperplasia in Italy

Italy29 participantsStarted 2020-10-23

Plain-language summary

Oservational, retrospective, multicenter study focused on neonatal screening for Congenital Adreanl Hyperplasia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Neonatal who underwent neonatal screening for congenital adrenal hyperplasia between January 2006 and December 2019 at participating centres; * Patients diagnosed with Congenital Adrenal Hyperplasia; * Obtaining informed consent. Exclusion Criteria: • None.

What they're measuring

Incidence of classic Congenital Adrenal Hyperplasia in neonates who underwent neonatal screening in the reporting period

Timeframe: at baseline

Sensibility of Neonatal Screening for classic Congenital Adrenal Hyperplasia

Timeframe: at baseline

Positive predictive rate

Timeframe: at baseline

Trial details

NCT IDNCT06728748

SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Congenital Adrenal Hyperplasia trials